Copyright Reports & Markets. All rights reserved.

Global Histone Deacetylase (HDAC) Inhibitors Market Insights, Forecast to 2025

Request for Sample of this report
Buy now

Table of Contents

    1 Histone Deacetylase (HDAC) Inhibitors Market Overview

    • 1.1 Product Overview and Scope of Histone Deacetylase (HDAC) Inhibitors
    • 1.2 Histone Deacetylase (HDAC) Inhibitors Segment by Type
      • 1.2.1 Global Histone Deacetylase (HDAC) Inhibitors Sales Growth Rate Comparison by Type (2021-2026)
      • 1.2.2 Fatty Acid
      • 1.2.3 Hydroxamate
      • 1.2.4 Cyclic Peptide
      • 1.2.5 Benzamide
    • 1.3 Histone Deacetylase (HDAC) Inhibitors Segment by Application
      • 1.3.1 Histone Deacetylase (HDAC) Inhibitors Sales Comparison by Application: 2020 VS 2026
      • 1.3.2 Treatment of Malignant Tumors
      • 1.3.3 Chronic Disease Treatment
      • 1.3.4 Others
    • 1.4 Global Histone Deacetylase (HDAC) Inhibitors Market Size Estimates and Forecasts
      • 1.4.1 Global Histone Deacetylase (HDAC) Inhibitors Revenue 2015-2026
      • 1.4.2 Global Histone Deacetylase (HDAC) Inhibitors Sales 2015-2026
      • 1.4.3 Histone Deacetylase (HDAC) Inhibitors Market Size by Region: 2020 Versus 2026

    2 Global Histone Deacetylase (HDAC) Inhibitors Market Competition by Manufacturers

    • 2.1 Global Histone Deacetylase (HDAC) Inhibitors Sales Market Share by Manufacturers (2015-2020)
    • 2.2 Global Histone Deacetylase (HDAC) Inhibitors Revenue Share by Manufacturers (2015-2020)
    • 2.3 Global Histone Deacetylase (HDAC) Inhibitors Average Price by Manufacturers (2015-2020)
    • 2.4 Manufacturers Histone Deacetylase (HDAC) Inhibitors Manufacturing Sites, Area Served, Product Type
    • 2.5 Histone Deacetylase (HDAC) Inhibitors Market Competitive Situation and Trends
      • 2.5.1 Histone Deacetylase (HDAC) Inhibitors Market Concentration Rate
      • 2.5.2 Global Top 5 and Top 10 Players Market Share by Revenue
      • 2.5.3 Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
    • 2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
    • 2.7 Primary Interviews with Key Histone Deacetylase (HDAC) Inhibitors Players (Opinion Leaders)

    3 Histone Deacetylase (HDAC) Inhibitors Retrospective Market Scenario by Region

    • 3.1 Global Histone Deacetylase (HDAC) Inhibitors Retrospective Market Scenario in Sales by Region: 2015-2020
    • 3.2 Global Histone Deacetylase (HDAC) Inhibitors Retrospective Market Scenario in Revenue by Region: 2015-2020
    • 3.3 North America Histone Deacetylase (HDAC) Inhibitors Market Facts & Figures by Country
      • 3.3.1 North America Histone Deacetylase (HDAC) Inhibitors Sales by Country
      • 3.3.2 North America Histone Deacetylase (HDAC) Inhibitors Sales by Country
      • 3.3.3 U.S.
      • 3.3.4 Canada
    • 3.4 Europe Histone Deacetylase (HDAC) Inhibitors Market Facts & Figures by Country
      • 3.4.1 Europe Histone Deacetylase (HDAC) Inhibitors Sales by Country
      • 3.4.2 Europe Histone Deacetylase (HDAC) Inhibitors Sales by Country
      • 3.4.3 Germany
      • 3.4.4 France
      • 3.4.5 U.K.
      • 3.4.6 Italy
      • 3.4.7 Russia
    • 3.5 Asia Pacific Histone Deacetylase (HDAC) Inhibitors Market Facts & Figures by Region
      • 3.5.1 Asia Pacific Histone Deacetylase (HDAC) Inhibitors Sales by Region
      • 3.5.2 Asia Pacific Histone Deacetylase (HDAC) Inhibitors Sales by Region
      • 3.5.3 China
      • 3.5.4 Japan
      • 3.5.5 South Korea
      • 3.5.6 India
      • 3.5.7 Australia
      • 3.5.8 Taiwan
      • 3.5.9 Indonesia
      • 3.5.10 Thailand
      • 3.5.11 Malaysia
      • 3.5.12 Philippines
      • 3.5.13 Vietnam
    • 3.6 Latin America Histone Deacetylase (HDAC) Inhibitors Market Facts & Figures by Country
      • 3.6.1 Latin America Histone Deacetylase (HDAC) Inhibitors Sales by Country
      • 3.6.2 Latin America Histone Deacetylase (HDAC) Inhibitors Sales by Country
      • 3.6.3 Mexico
      • 3.6.3 Brazil
      • 3.6.3 Argentina
    • 3.7 Middle East and Africa Histone Deacetylase (HDAC) Inhibitors Market Facts & Figures by Country
      • 3.7.1 Middle East and Africa Histone Deacetylase (HDAC) Inhibitors Sales by Country
      • 3.7.2 Middle East and Africa Histone Deacetylase (HDAC) Inhibitors Sales by Country
      • 3.7.3 Turkey
      • 3.7.4 Saudi Arabia
      • 3.7.5 U.A.E

    4 Global Histone Deacetylase (HDAC) Inhibitors Historic Market Analysis by Type

    • 4.1 Global Histone Deacetylase (HDAC) Inhibitors Sales Market Share by Type (2015-2020)
    • 4.2 Global Histone Deacetylase (HDAC) Inhibitors Revenue Market Share by Type (2015-2020)
    • 4.3 Global Histone Deacetylase (HDAC) Inhibitors Price Market Share by Type (2015-2020)
    • 4.4 Global Histone Deacetylase (HDAC) Inhibitors Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End

    5 Global Histone Deacetylase (HDAC) Inhibitors Historic Market Analysis by Application

    • 5.1 Global Histone Deacetylase (HDAC) Inhibitors Sales Market Share by Application (2015-2020)
    • 5.2 Global Histone Deacetylase (HDAC) Inhibitors Revenue Market Share by Application (2015-2020)
    • 5.3 Global Histone Deacetylase (HDAC) Inhibitors Price by Application (2015-2020)

    6 Company Profiles and Key Figures in Histone Deacetylase (HDAC) Inhibitors Business

    • 6.1 4SC
      • 6.1.1 Corporation Information
      • 6.1.2 4SC Description, Business Overview and Total Revenue
      • 6.1.3 4SC Histone Deacetylase (HDAC) Inhibitors Sales, Revenue and Gross Margin (2015-2020)
      • 6.1.4 4SC Products Offered
      • 6.1.5 4SC Recent Development
    • 6.2 Acetylon Pharmaceuticals
      • 6.2.1 Acetylon Pharmaceuticals Histone Deacetylase (HDAC) Inhibitors Production Sites and Area Served
      • 6.2.2 Acetylon Pharmaceuticals Description, Business Overview and Total Revenue
      • 6.2.3 Acetylon Pharmaceuticals Histone Deacetylase (HDAC) Inhibitors Sales, Revenue and Gross Margin (2015-2020)
      • 6.2.4 Acetylon Pharmaceuticals Products Offered
      • 6.2.5 Acetylon Pharmaceuticals Recent Development
    • 6.3 Celleron Therapeutics
      • 6.3.1 Celleron Therapeutics Histone Deacetylase (HDAC) Inhibitors Production Sites and Area Served
      • 6.3.2 Celleron Therapeutics Description, Business Overview and Total Revenue
      • 6.3.3 Celleron Therapeutics Histone Deacetylase (HDAC) Inhibitors Sales, Revenue and Gross Margin (2015-2020)
      • 6.3.4 Celleron Therapeutics Products Offered
      • 6.3.5 Celleron Therapeutics Recent Development
    • 6.4 Chipscreen Biosciences
      • 6.4.1 Chipscreen Biosciences Histone Deacetylase (HDAC) Inhibitors Production Sites and Area Served
      • 6.4.2 Chipscreen Biosciences Description, Business Overview and Total Revenue
      • 6.4.3 Chipscreen Biosciences Histone Deacetylase (HDAC) Inhibitors Sales, Revenue and Gross Margin (2015-2020)
      • 6.4.4 Chipscreen Biosciences Products Offered
      • 6.4.5 Chipscreen Biosciences Recent Development
    • 6.5 Chroma Therapeutics
      • 6.5.1 Chroma Therapeutics Histone Deacetylase (HDAC) Inhibitors Production Sites and Area Served
      • 6.5.2 Chroma Therapeutics Description, Business Overview and Total Revenue
      • 6.5.3 Chroma Therapeutics Histone Deacetylase (HDAC) Inhibitors Sales, Revenue and Gross Margin (2015-2020)
      • 6.5.4 Chroma Therapeutics Products Offered
      • 6.5.5 Chroma Therapeutics Recent Development
    • 6.6 CrystalGenomics
      • 6.6.1 CrystalGenomics Histone Deacetylase (HDAC) Inhibitors Production Sites and Area Served
      • 6.6.2 CrystalGenomics Description, Business Overview and Total Revenue
      • 6.6.3 CrystalGenomics Histone Deacetylase (HDAC) Inhibitors Sales, Revenue and Gross Margin (2015-2020)
      • 6.6.4 CrystalGenomics Products Offered
      • 6.6.5 CrystalGenomics Recent Development
    • 6.7 Curis
      • 6.6.1 Curis Histone Deacetylase (HDAC) Inhibitors Production Sites and Area Served
      • 6.6.2 Curis Description, Business Overview and Total Revenue
      • 6.6.3 Curis Histone Deacetylase (HDAC) Inhibitors Sales, Revenue and Gross Margin (2015-2020)
      • 6.4.4 Curis Products Offered
      • 6.7.5 Curis Recent Development
    • 6.8 MEI Pharma
      • 6.8.1 MEI Pharma Histone Deacetylase (HDAC) Inhibitors Production Sites and Area Served
      • 6.8.2 MEI Pharma Description, Business Overview and Total Revenue
      • 6.8.3 MEI Pharma Histone Deacetylase (HDAC) Inhibitors Sales, Revenue and Gross Margin (2015-2020)
      • 6.8.4 MEI Pharma Products Offered
      • 6.8.5 MEI Pharma Recent Development
    • 6.9 Mirati Therapeutics
      • 6.9.1 Mirati Therapeutics Histone Deacetylase (HDAC) Inhibitors Production Sites and Area Served
      • 6.9.2 Mirati Therapeutics Description, Business Overview and Total Revenue
      • 6.9.3 Mirati Therapeutics Histone Deacetylase (HDAC) Inhibitors Sales, Revenue and Gross Margin (2015-2020)
      • 6.9.4 Mirati Therapeutics Products Offered
      • 6.9.5 Mirati Therapeutics Recent Development
    • 6.10 Novartis
      • 6.10.1 Novartis Histone Deacetylase (HDAC) Inhibitors Production Sites and Area Served
      • 6.10.2 Novartis Description, Business Overview and Total Revenue
      • 6.10.3 Novartis Histone Deacetylase (HDAC) Inhibitors Sales, Revenue and Gross Margin (2015-2020)
      • 6.10.4 Novartis Products Offered
      • 6.10.5 Novartis Recent Development
    • 6.11 Onxeo
      • 6.11.1 Onxeo Histone Deacetylase (HDAC) Inhibitors Production Sites and Area Served
      • 6.11.2 Onxeo Histone Deacetylase (HDAC) Inhibitors Description, Business Overview and Total Revenue
      • 6.11.3 Onxeo Histone Deacetylase (HDAC) Inhibitors Sales, Revenue and Gross Margin (2015-2020)
      • 6.11.4 Onxeo Products Offered
      • 6.11.5 Onxeo Recent Development
    • 6.12 Repligen
      • 6.12.1 Repligen Histone Deacetylase (HDAC) Inhibitors Production Sites and Area Served
      • 6.12.2 Repligen Histone Deacetylase (HDAC) Inhibitors Description, Business Overview and Total Revenue
      • 6.12.3 Repligen Histone Deacetylase (HDAC) Inhibitors Sales, Revenue and Gross Margin (2015-2020)
      • 6.12.4 Repligen Products Offered
      • 6.12.5 Repligen Recent Development
    • 6.13 TetraLogic
      • 6.13.1 TetraLogic Histone Deacetylase (HDAC) Inhibitors Production Sites and Area Served
      • 6.13.2 TetraLogic Histone Deacetylase (HDAC) Inhibitors Description, Business Overview and Total Revenue
      • 6.13.3 TetraLogic Histone Deacetylase (HDAC) Inhibitors Sales, Revenue and Gross Margin (2015-2020)
      • 6.13.4 TetraLogic Products Offered
      • 6.13.5 TetraLogic Recent Development

    7 Histone Deacetylase (HDAC) Inhibitors Manufacturing Cost Analysis

    • 7.1 Histone Deacetylase (HDAC) Inhibitors Key Raw Materials Analysis
      • 7.1.1 Key Raw Materials
      • 7.1.2 Key Raw Materials Price Trend
      • 7.1.3 Key Suppliers of Raw Materials
    • 7.2 Proportion of Manufacturing Cost Structure
    • 7.3 Manufacturing Process Analysis of Histone Deacetylase (HDAC) Inhibitors
    • 7.4 Histone Deacetylase (HDAC) Inhibitors Industrial Chain Analysis

    8 Marketing Channel, Distributors and Customers

    • 8.1 Marketing Channel
    • 8.2 Histone Deacetylase (HDAC) Inhibitors Distributors List
    • 8.3 Histone Deacetylase (HDAC) Inhibitors Customers

    9 Market Dynamics

    • 9.1 Market Trends
    • 9.2 Opportunities and Drivers
    • 9.3 Challenges
    • 9.4 Porter's Five Forces Analysis

    10 Global Market Forecast

    • 10.1 Global Histone Deacetylase (HDAC) Inhibitors Market Estimates and Projections by Type
      • 10.1.1 Global Forecasted Sales of Histone Deacetylase (HDAC) Inhibitors by Type (2021-2026)
      • 10.1.2 Global Forecasted Revenue of Histone Deacetylase (HDAC) Inhibitors by Type (2021-2026)
    • 10.2 Histone Deacetylase (HDAC) Inhibitors Market Estimates and Projections by Application
      • 10.2.1 Global Forecasted Sales of Histone Deacetylase (HDAC) Inhibitors by Application (2021-2026)
      • 10.2.2 Global Forecasted Revenue of Histone Deacetylase (HDAC) Inhibitors by Application (2021-2026)
    • 10.3 Histone Deacetylase (HDAC) Inhibitors Market Estimates and Projections by Region
      • 10.3.1 Global Forecasted Sales of Histone Deacetylase (HDAC) Inhibitors by Region (2021-2026)
      • 10.3.2 Global Forecasted Revenue of Histone Deacetylase (HDAC) Inhibitors by Region (2021-2026)
    • 10.4 North America Histone Deacetylase (HDAC) Inhibitors Estimates and Projections (2021-2026)
    • 10.5 Europe Histone Deacetylase (HDAC) Inhibitors Estimates and Projections (2021-2026)
    • 10.6 Asia Pacific Histone Deacetylase (HDAC) Inhibitors Estimates and Projections (2021-2026)
    • 10.7 Latin America Histone Deacetylase (HDAC) Inhibitors Estimates and Projections (2021-2026)
    • 10.8 Middle East and Africa Histone Deacetylase (HDAC) Inhibitors Estimates and Projections (2021-2026)

    11 Research Finding and Conclusion

      12 Methodology and Data Source

      • 12.1 Methodology/Research Approach
        • 12.1.1 Research Programs/Design
        • 12.1.2 Market Size Estimation
        • 12.1.3 Market Breakdown and Data Triangulation
      • 12.2 Data Source
        • 12.2.1 Secondary Sources
        • 12.2.2 Primary Sources
      • 12.3 Author List

      The global Histone Deacetylase (HDAC) Inhibitors market is valued at US$ xx million in 2020 is expected to reach US$ xx million by the end of 2026, growing at a CAGR of xx% during 2021-2026.
      This report focuses on Histone Deacetylase (HDAC) Inhibitors volume and value at the global level, regional level and company level. From a global perspective, this report represents overall Histone Deacetylase (HDAC) Inhibitors market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan etc.
      Market Segment Analysis
      The research report includes specific segments by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2015 to 2026. Understanding the segments helps in identifying the importance of different factors that aid the market growth.
      Segment by Type, the Histone Deacetylase (HDAC) Inhibitors market is segmented into
      Fatty Acid
      Hydroxamate
      Cyclic Peptide
      Benzamide

      Segment by Application
      Treatment of Malignant Tumors
      Chronic Disease Treatment
      Others

      Global Histone Deacetylase (HDAC) Inhibitors Market: Regional Analysis
      The Histone Deacetylase (HDAC) Inhibitors market is analysed and market size information is provided by regions (countries). The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type and by Application segment in terms of sales and revenue for the period 2015-2026.
      The key regions covered in the Histone Deacetylase (HDAC) Inhibitors market report are:
      North America
      U.S.
      Canada
      Europe
      Germany
      France
      U.K.
      Italy
      Russia
      Asia-Pacific
      China
      Japan
      South Korea
      India
      Australia
      Taiwan
      Indonesia
      Thailand
      Malaysia
      Philippines
      Vietnam
      Latin America
      Mexico
      Brazil
      Argentina
      Middle East & Africa
      Turkey
      Saudi Arabia
      U.A.E
      Global Histone Deacetylase (HDAC) Inhibitors Market: Competitive Analysis
      This section of the report identifies various key manufacturers of the market. It helps the reader understand the strategies and collaborations that players are focusing on combat competition in the market. The comprehensive report provides a significant microscopic look at the market. The reader can identify the footprints of the manufacturers by knowing about the global revenue of manufacturers, the global price of manufacturers, and sales by manufacturers during the forecast period of 2015 to 2019.
      The major players in global Histone Deacetylase (HDAC) Inhibitors market include:
      4SC
      Acetylon Pharmaceuticals
      Celleron Therapeutics
      Chipscreen Biosciences
      Chroma Therapeutics
      CrystalGenomics
      Curis
      MEI Pharma
      Mirati Therapeutics
      Novartis
      Onxeo
      Repligen
      TetraLogic

      Buy now